About Aegerion
Aegerion is a company based in Cambridge (United States) founded in 2005 was acquired by Amryt Pharma in May 2019.. Aegerion has raised $58.42 million across 7 funding rounds from investors including Amryt Pharma, MVM Partners and QLT. The company has 63 employees as of December 31, 2021. Aegerion has completed 1 acquisition, including Myalept. Aegerion operates in a competitive market with competitors including Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others.
- Headquarter Cambridge, United States
- Employees 63 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aegerion Pharmaceuticals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$58.42 M (USD)
in 7 rounds
-
Latest Funding Round
$72.5 M (USD), Debt – Conventional
Nov 01, 2018
-
Investors
Amryt Pharma
& 9 more
-
Employee Count
63
as on Dec 31, 2021
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aegerion
Aegerion has successfully raised a total of $58.42M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $72.5 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Debt – Conventional — $72.5M
-
First Round
First Round
(13 Jun 2006)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Debt – Conventional - Aegerion | Valuation |
investors |
|
| Apr, 2018 | Amount | Debt – Conventional - Aegerion | Valuation |
investors |
|
| Aug, 2014 | Amount | Post-IPO - Aegerion | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aegerion
Aegerion has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Amryt Pharma, MVM Partners and QLT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Investment opportunities in healthcare are managed by Broadfin Capital.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aegerion
Aegerion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Myalept. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Leptin replacement therapy is provided for generalized lipodystrophy patients.
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Aegerion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aegerion Comparisons
Competitors of Aegerion
Aegerion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Regenerative medicine for cardiovascular disorders is developed using cell-based platforms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aegerion
Frequently Asked Questions about Aegerion
When was Aegerion founded?
Aegerion was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Where is Aegerion located?
Aegerion is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Aegerion a funded company?
Aegerion is a funded company, having raised a total of $58.42M across 7 funding rounds to date. The company's 1st funding round was a Post-IPO of $325M, raised on Jun 13, 2006.
How many employees does Aegerion have?
As of Dec 31, 2021, the latest employee count at Aegerion is 63.
What does Aegerion do?
Aegerion Pharmaceuticals was established in 2005 in Cambridge, United States, within the biopharmaceutical sector. Treatments for cardiovascular and metabolic diseases are developed, including Juxtapid, which lowers low-density lipoprotein cholesterol levels, and Myalept, acquired from AstraZeneca for 325 million to address leptin deficiency complications in generalized lipodystrophy patients. Emphasis is given to solutions for hyperlipidemia assessment and management.
Who are the top competitors of Aegerion?
Aegerion's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.
How many acquisitions has Aegerion made?
Aegerion has made 1 acquisition, including Myalept.
Who are Aegerion's investors?
Aegerion has 10 investors. Key investors include Amryt Pharma, MVM Partners, QLT, Athyrium Capital Management, and Highbridge.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.